Company: ABUS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001447028-25-000126
Chunk: 66

Company: Arbutus Biopharma Corp
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 66
---
 apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.  

We believe there have been no significant changes in our critical accounting policies and estimates as discussed in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2024.

RECENT ACCOUNTING PRONOUNCEMENTS

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that are adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.

Please refer to Note 2 to our condensed consolidated financial statements included in “Part I, Item 1-Financial Statements (Unaudited)” of this Form 10-Q for a description of recent accounting pronouncements applicable to our business.

RESULTS OF OPERATIONS

The following summarizes the results of our operations for the periods shown:

 Three Months Ended September 30,Nine Months Ended September 30, 2025202420252024(in thousands)Total revenue$529 $1,339 $13,032 $4,597 Operating expenses9,188 22,779 45,902 66,983 Loss from operations(8,659)(21,440)(32,870)(62,386)Other income917 1,723 3,125 4,998 Net loss$(7,742)$(19,717)$(29,745)$(57,388)

30

Revenue 

Revenues are summarized in the following tables: 

Three Months Ended September 30,2025% of Total2024% of Total(in thousands, except percentages)Revenue from collaborations and licensesRoyalties from sales of ONPATTRO$280 53 %$644 48 %Qilu Pharmaceutical Co., Ltd.— — %123 9 %Non-cash royalty revenueRoyalties from sales of ONPATTRO249 47 %572 43 %Total revenue$529 100 %$1,339 100 %

Nine Months Ended September 30,2025% of Total2024% of Total(in thousands, except percentages)Revenue from collaborations and licensesRoyalties from sales of ONPATTRO$1,375 11 %$1,981